Clinical efficacy and safety: allergy/immunology

The European Medicines Agency's scientific guidelines on the clinical evaluation of human medicines used for allergies and related diseases of the immune system help medicine developers prepare marketing-authorisation applications.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

Guidelines

• Clinical investigation of immunosuppressants for solid organ transplantation
• Clinical development of medicinal products for the treatment of allergic rhino-conjunctivitis
• Clinical development of products for specific immunotherapy for the treatment of allergic diseases